Investment Thesis
Achieve Life Sciences is a pre-revenue or failed-commercialization biotech company burning $6.9M annually in operating cash flow with zero revenue generation. Despite maintaining a strong cash position of $28.1M and zero debt, the company exhibits unsustainable fundamentals with $54.6M in operating losses and negative ROE (-95.2%), indicating operational failure in its diagnostic substances business.
Strengths
- Strong cash position of $28.1M providing runway for operations
- Zero debt burden with clean balance sheet (Debt/Equity: 0.00x)
- Adequate liquidity with Current Ratio of 2.62x reducing bankruptcy risk
Risks
- Zero revenue indicating complete lack of commercial success or market traction
- Substantial operating losses of $54.6M with negative cash flow despite cash reserves
- Negative returns metrics (ROE -95.2%, ROA -30.7%) signaling fundamental business failure
- Unsustainable cash burn rate will deplete reserves within ~4 years at current trajectory
- No evidence of revenue generation path or viable product commercialization
Key Metrics to Watch
- Revenue generation and first commercial sales event
- Quarterly operating cash flow trend and burn rate acceleration/deceleration
- Cash balance trajectory and projected runway to profitability or funding events
Financial Metrics
Revenue
0.0
Net Income
-10.2M
EPS (Diluted)
$-0.19
Free Cash Flow
-6.9M
Total Assets
33.1M
Cash
28.1M
Profitability Ratios
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
ROE
-95.2%
ROA
-30.7%
FCF Margin
N/A
Balance Sheet & Liquidity
Current Ratio
2.62x
Quick Ratio
2.62x
Debt/Equity
0.00x
Debt/Assets
67.7%
Interest Coverage
-27.56x
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-14T07:45:40.691662 |
Data as of: 2026-03-31 |
Powered by Claude AI